Economic portfolio
DSP Nifty Healthcare Index Fund
DSP DSP Mutual Fund Jun 2025 — Sep 2026 16 months
Data periodFund holdingsSep 2026NSE prices23 Oct 2026Data status →
Days to sell half: 0.0 — selling half of every holding at 20% of each stock’s usual daily NSE trading, the time to get through 90% of the portfolio (Sep 2026). Quick to unwind on normal volumes. Small-cap comparison →
Shares of this fund’s disclosed Indian listed equity, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not included, so for a hybrid or debt fund these are shares of its equity part only. Not performance, and not a recommendation.
How concentrated it has been
16 priced months, Jun 2025 to Sep 2026 · at each month’s NSE closes
Top 10 holdings, share of equity
75.8% now, 76.7% in Sep 2025 · highest 78.1%, lowest 75.8%
Companies held
20 now, 20 in Sep 2025 · largest single holding 17.0% of equity
How it trades: no clear lean toward recent winners or losers (score -0.04 over 15 months; −1 always buys the biggest fallers, +1 the biggest risers, 0 no pattern). Value and contra funds average −0.10, other active funds about 0. A description of behaviour, not of results. How this was tested →
Sector mix
Share of the equity shown · NSE industry
Funds most like this one
Overlap of disclosed equity · the smaller share of each company both hold, added up
- ICICI Prudential Nifty Healthcare ETFICICI Prudential · 20 shared100.0%
- Axis NIFTY Healthcare ETFAxis · 20 shared100.0%
- DSP Nifty Healthcare ETFDSP · 20 shared100.0%
- ADITYA BIRLA SUN LIFE NIFTY HEALTHCARE ETFAditya Birla Sun Life · 20 shared99.9%
- EODWHFEdelweiss · 18 shared91.8%
- Nippon India Nifty Pharma ETFNippon India · 16 shared81.1%
- ICICI Prudential Nifty Pharma Index FundICICI Prudential · 16 shared81.1%
- Mirae Asset Nifty 500 Healthcare ETFMirae Asset · 20 shared79.8%
Select one to see exactly what the two funds share. Index funds and ETFs tracking the same index overlap almost completely.
What changed in Sep 2026
This portfolio’s consecutive disclosures · evidenced adjustments applied
New positions
Complete exits
Largest increases
- 01 Sun Pharmaceutical Industries Limited+0.8% +188
- 02 Max Healthcare Institute Limited+0.8% +132
- 03 Dr. Reddy's Laboratories Limited+0.9% +114
- 04 Cipla Limited+0.8% +102
- 05 Fortis Healthcare Limited+0.8% +92
- 06 Laurus Labs Limited+0.9% +78
- 07 Alkem Laboratories Limited+3.9% +50
- 08 Lupin Limited+0.8% +45
- 09 Aurobindo Pharma Limited+0.7% +40
- 10 Torrent Pharmaceuticals Limited+1.2% +37
Largest reductions
Share quantities, not market values or cash flows.
Holdings by value
Sep 2026 · largest 100 · share of the equity shown
| Company | Sector | Size | Share of equity | Value | Shares held | Held since |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | Healthcare | Large Cap | 17.00% | 4.24 Cr | 23,332 | by Jun 2025 (16 mo+) |
| Divi's Laboratories Limited | Healthcare | Large Cap | 10.44% | 2.60 Cr | 2,800 | by Jun 2025 (16 mo+) |
| Apollo Hospitals Enterprise Limited | Healthcare | Large Cap | 7.43% | 1.85 Cr | 2,268 | by Jun 2025 (16 mo+) |
| Laurus Labs Limited | Healthcare | Mid Cap | 6.82% | 1.70 Cr | 8,582 | by Jun 2025 (16 mo+) |
| Cipla Limited | Healthcare | Large Cap | 6.70% | 1.67 Cr | 12,401 | by Jun 2025 (16 mo+) |
| Dr. Reddy's Laboratories Limited | Healthcare | Large Cap | 6.65% | 1.66 Cr | 13,438 | by Jun 2025 (16 mo+) |
| Torrent Pharmaceuticals Limited | Healthcare | Large Cap | 6.24% | 1.56 Cr | 3,243 | by Jun 2025 (16 mo+) |
| Max Healthcare Institute Limited | Healthcare | Large Cap | 6.12% | 1.52 Cr | 16,399 | by Jun 2025 (16 mo+) |
| Lupin Limited | Healthcare | Mid Cap | 4.36% | 1.09 Cr | 5,353 | by Jun 2025 (16 mo+) |
| Aurobindo Pharma Limited | Healthcare | Mid Cap | 4.08% | 1.02 Cr | 6,090 | by Jun 2025 (16 mo+) |
| Fortis Healthcare Limited | Healthcare | Mid Cap | 3.55% | 0.88 Cr | 11,482 | by Jun 2025 (16 mo+) |
| Glenmark Pharmaceuticals Limited | Healthcare | Mid Cap | 3.11% | 0.77 Cr | 3,318 | by Jun 2025 (16 mo+) |
| Alkem Laboratories Limited | Healthcare | Mid Cap | 2.75% | 0.69 Cr | 1,329 | by Jun 2025 (16 mo+) |
| Zydus Lifesciences Limited | Healthcare | Mid Cap | 2.55% | 0.63 Cr | 5,460 | by Jun 2025 (16 mo+) |
| Mankind Pharma Limited | Healthcare | Mid Cap | 2.51% | 0.63 Cr | 2,497 | by Jun 2025 (16 mo+) |
| IPCA Laboratories Limited | Healthcare | Mid Cap | 2.37% | 0.59 Cr | 3,061 | by Jun 2025 (16 mo+) |
| Biocon Limited | Healthcare | Mid Cap | 2.28% | 0.57 Cr | 15,357 | by Jun 2025 (16 mo+) |
| Gland Pharma Limited | Healthcare | Small Cap | 2.04% | 0.51 Cr | 1,756 | Sep 2026 (1 mo) |
| Krishna Institute of Medical Sciences Limited | Healthcare | Small Cap | 1.76% | 0.44 Cr | 5,880 | Sep 2026 (1 mo) |
| Abbott India Limited | Healthcare | Mid Cap | 1.25% | 0.31 Cr | 115 | by Jun 2025 (16 mo+) |
Half of its current holdings have been held for 16 disclosed months or more without a break. “By” means held in the first month we have for this fund, so possibly for longer. Counted over this fund’s own monthly disclosures; a merger (e.g. HDFC into HDFC Bank, July 2023) starts a new run for the surviving company.
Recent position changes
Latest 100 company-month records · evidenced adjustments applied
| Company | Month | Activity | Adjusted change |
|---|---|---|---|
| Piramal Pharma Limited | Sep 2026 | ▼ Complete exit | -13,595 |
| Krishna Institute of Medical Sciences Limited | Sep 2026 | ▲ New position | +5,880 |
| Syngene International Limited | Sep 2026 | ▼ Complete exit | -4,155 |
| Gland Pharma Limited | Sep 2026 | ▲ New position | +1,756 |
| Biocon Limited | Sep 2026 | ▼ Reducing | -237 |
| Sun Pharmaceutical Industries Limited | Sep 2026 | ▲ Increasing | +188 |
| Max Healthcare Institute Limited | Sep 2026 | ▲ Increasing | +132 |
| Dr. Reddy's Laboratories Limited | Sep 2026 | ▲ Increasing | +114 |
| Cipla Limited | Sep 2026 | ▲ Increasing | +102 |
| Fortis Healthcare Limited | Sep 2026 | ▲ Increasing | +92 |
| Laurus Labs Limited | Sep 2026 | ▲ Increasing | +78 |
| Alkem Laboratories Limited | Sep 2026 | ▲ Increasing | +50 |
| Lupin Limited | Sep 2026 | ▲ Increasing | +45 |
| Aurobindo Pharma Limited | Sep 2026 | ▲ Increasing | +40 |
| Torrent Pharmaceuticals Limited | Sep 2026 | ▲ Increasing | +37 |
| Glenmark Pharmaceuticals Limited | Sep 2026 | ▲ Increasing | +27 |
| IPCA Laboratories Limited | Sep 2026 | ▲ Increasing | +25 |
| Mankind Pharma Limited | Sep 2026 | ▲ Increasing | +23 |
| Divi's Laboratories Limited | Sep 2026 | ▲ Increasing | +23 |
| Apollo Hospitals Enterprise Limited | Sep 2026 | ▲ Increasing | +19 |
| Zydus Lifesciences Limited | Sep 2026 | ▼ Reducing | -8 |
| Abbott India Limited | Sep 2026 | ▲ Increasing | +2 |
| Sun Pharmaceutical Industries Limited | Aug 2026 | ▲ Increasing | +1,237 |
| Max Healthcare Institute Limited | Aug 2026 | ▲ Increasing | +870 |
| Biocon Limited | Aug 2026 | ▲ Increasing | +834 |
| Piramal Pharma Limited | Aug 2026 | ▲ Increasing | +727 |
| Dr. Reddy's Laboratories Limited | Aug 2026 | ▲ Increasing | +712 |
| Cipla Limited | Aug 2026 | ▲ Increasing | +658 |
| Fortis Healthcare Limited | Aug 2026 | ▲ Increasing | +609 |
| Laurus Labs Limited | Aug 2026 | ▲ Increasing | +454 |
| Aurobindo Pharma Limited | Aug 2026 | ▲ Increasing | +323 |
| Zydus Lifesciences Limited | Aug 2026 | ▲ Increasing | +292 |
| Lupin Limited | Aug 2026 | ▲ Increasing | +283 |
| Syngene International Limited | Aug 2026 | ▲ Increasing | +221 |
| Glenmark Pharmaceuticals Limited | Aug 2026 | ▲ Increasing | +176 |
| Torrent Pharmaceuticals Limited | Aug 2026 | ▲ Increasing | +171 |
| IPCA Laboratories Limited | Aug 2026 | ▲ Increasing | +162 |
| Divi's Laboratories Limited | Aug 2026 | ▲ Increasing | +147 |
| Mankind Pharma Limited | Aug 2026 | ▲ Increasing | +131 |
| Apollo Hospitals Enterprise Limited | Aug 2026 | ▲ Increasing | +119 |
| Alkem Laboratories Limited | Aug 2026 | ▲ Increasing | +68 |
| Abbott India Limited | Aug 2026 | ▲ Increasing | +5 |
| Torrent Pharmaceuticals Limited | Jul 2026 | ▲ Increasing | +923 |
| Sun Pharmaceutical Industries Limited | Jul 2026 | ▲ Increasing | +591 |
| Max Healthcare Institute Limited | Jul 2026 | ▲ Increasing | +415 |
| Biocon Limited | Jul 2026 | ▲ Increasing | +398 |
| Piramal Pharma Limited | Jul 2026 | ▲ Increasing | +347 |
| Dr. Reddy's Laboratories Limited | Jul 2026 | ▲ Increasing | +341 |
| Cipla Limited | Jul 2026 | ▲ Increasing | +314 |
| Fortis Healthcare Limited | Jul 2026 | ▲ Increasing | +291 |
| Laurus Labs Limited | Jul 2026 | ▲ Increasing | +218 |
| Aurobindo Pharma Limited | Jul 2026 | ▲ Increasing | +155 |
| Zydus Lifesciences Limited | Jul 2026 | ▲ Increasing | +140 |
| Lupin Limited | Jul 2026 | ▲ Increasing | +137 |
| Syngene International Limited | Jul 2026 | ▲ Increasing | +107 |
| Glenmark Pharmaceuticals Limited | Jul 2026 | ▲ Increasing | +84 |
| IPCA Laboratories Limited | Jul 2026 | ▲ Increasing | +78 |
| Divi's Laboratories Limited | Jul 2026 | ▲ Increasing | +72 |
| Mankind Pharma Limited | Jul 2026 | ▲ Increasing | +64 |
| Apollo Hospitals Enterprise Limited | Jul 2026 | ▲ Increasing | +59 |
| Alkem Laboratories Limited | Jul 2026 | ▲ Increasing | +34 |
| Abbott India Limited | Jul 2026 | ▲ Increasing | +4 |
| Sun Pharmaceutical Industries Limited | Jun 2026 | ▲ Increasing | +646 |
| Max Healthcare Institute Limited | Jun 2026 | ▲ Increasing | +456 |
| Biocon Limited | Jun 2026 | ▲ Increasing | +429 |
| Piramal Pharma Limited | Jun 2026 | ▲ Increasing | +424 |
| Dr. Reddy's Laboratories Limited | Jun 2026 | ▲ Increasing | +375 |
| Cipla Limited | Jun 2026 | ▲ Increasing | +344 |
| Fortis Healthcare Limited | Jun 2026 | ▲ Increasing | +317 |
| Laurus Labs Limited | Jun 2026 | ▲ Increasing | +237 |
| Lupin Limited | Jun 2026 | ▲ Increasing | +154 |
| Zydus Lifesciences Limited | Jun 2026 | ▲ Increasing | +153 |
| Syngene International Limited | Jun 2026 | ▲ Increasing | +123 |
| Aurobindo Pharma Limited | Jun 2026 | ▲ Increasing | +115 |
| Glenmark Pharmaceuticals Limited | Jun 2026 | ▲ Increasing | +92 |
| IPCA Laboratories Limited | Jun 2026 | ▲ Increasing | +85 |
| Divi's Laboratories Limited | Jun 2026 | ▲ Increasing | +78 |
| Torrent Pharmaceuticals Limited | Jun 2026 | ▲ Increasing | +71 |
| Mankind Pharma Limited | Jun 2026 | ▲ Increasing | +71 |
| Apollo Hospitals Enterprise Limited | Jun 2026 | ▲ Increasing | +63 |
| Alkem Laboratories Limited | Jun 2026 | ▲ Increasing | +35 |
| Abbott India Limited | Jun 2026 | ▲ Increasing | +3 |
| Sun Pharmaceutical Industries Limited | May 2026 | ▲ Increasing | +1,198 |
| Max Healthcare Institute Limited | May 2026 | ▲ Increasing | +842 |
| Biocon Limited | May 2026 | ▲ Increasing | +808 |
| Piramal Pharma Limited | May 2026 | ▲ Increasing | +701 |
| Dr. Reddy's Laboratories Limited | May 2026 | ▲ Increasing | +689 |
| Cipla Limited | May 2026 | ▲ Increasing | +636 |
| Fortis Healthcare Limited | May 2026 | ▲ Increasing | +589 |
| Laurus Labs Limited | May 2026 | ▲ Increasing | +439 |
| Aurobindo Pharma Limited | May 2026 | ▲ Increasing | +316 |
| Zydus Lifesciences Limited | May 2026 | ▲ Increasing | +282 |
| Lupin Limited | May 2026 | ▲ Increasing | +273 |
| Syngene International Limited | May 2026 | ▲ Increasing | +214 |
| Glenmark Pharmaceuticals Limited | May 2026 | ▲ Increasing | +170 |
| IPCA Laboratories Limited | May 2026 | ▲ Increasing | +156 |
| Divi's Laboratories Limited | May 2026 | ▲ Increasing | +143 |
| Mankind Pharma Limited | May 2026 | ▲ Increasing | +127 |
| Torrent Pharmaceuticals Limited | May 2026 | ▲ Increasing | +117 |
| Apollo Hospitals Enterprise Limited | May 2026 | ▲ Increasing | +115 |
Changes compare consecutive month-end disclosures for this portfolio only.